PAN-Biotech RPMI 1640, w: L-Glutamine, w: 2.0 g/L NaHCO3

Introduction

RPMI 1640, also known as RPMI Medium, was originally developed at Roswell Park Memorial Institute (RPMI) in 1966 for the growth of human leukemia cells in monolayer or suspension cultures. RPMI media has since been found to be suitable for a wide variety of mammalian and hybridoma cells. We offer a variety of RPMI media to meet the needs of your specific applications.

Composition

PAN-Biotech RPMI 1640, w: L-Glutamine, w: 2.0 g/L NaHCO3

Specifications

Cat. No. P04-16500

Documents

• Product Composition
• Material Safety Data Sheet (MSDS)

Product References

• Gottmann, Pascal et al. “Heterogeneous Development of β-Cell Populations in Diabetes-Resistant and -Susceptible Mice.” Diabetes vol. 71,9 (2022): 1962-1978. doi:10.2337/db21-1030
• Bahmani Jalali, Houman et al. “Effective Neural Photostimulation Using Indium-Based Type-II Quantum Dots.” ACS nano vol. 12,8 (2018): 8104-8114. doi:10.1021/acsnano.8b02976
• Jogdand, Gajendra M et al. “Inducible Costimulator Expressing T Cells Promote Parasitic Growth During Blood Stage Plasmodium berghei ANKA Infection.” Frontiers in immunology vol. 9 1041. 28 May. 2018, doi:10.3389/fimmu.2018.01041
• Michl, Carina et al. “The Chemopreventive Phytochemical Moringin Isolated from Moringa oleifera Seeds Inhibits JAK/STAT Signaling.” PloS one vol. 11,6 e0157430. 15 Jun. 2016, doi:10.1371/journal.pone.0157430
• Pinz, Sophia et al. “Signal transducer and activator of transcription STAT5 is recruited to c-Myc super-enhancer.” BMC molecular biology vol. 17 10. 14 Apr. 2016, doi:10.1186/s12867-016-0063-y
• Capo, Alessandro et al. “SPR-Based Detection of ASF Virus in Cells.” International journal of molecular sciences vol. 23,13 7463. 5 Jul. 2022, doi:10.3390/ijms23137463
• Paulus, Jannik, and Norbert Sewald. “Synthesis and Evaluation of a Non-Peptide Small-Molecule Drug Conjugate Targeting Integrin α_Vβ₃.” Frontiers in chemistry vol. 10 869639. 11 Apr. 2022, doi:10.3389/fchem.2022.869639
• Rohrbacher, Lisa et al. “The PI3K∂-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated Immunosuppression.” Frontiers in immunology vol. 12 608625. 15 Mar. 2021, doi:10.3389/fimmu.2021.608625
• Darwiche, Walaa et al. “Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia.” Journal of experimental & clinical cancer research : CR vol. 39,1 228. 28 Oct. 2020, doi:10.1186/s13046-020-01738-0
• Peroumal, Doureradjou et al. “Inherent low Erk and p38 activity reduce Fas Ligand expression and degranulation in T helper 17 cells leading to activation induced cell death resistance.” Oncotarget vol. 7,34 (2016): 54339-54359. doi:10.18632/oncotarget.10913
• Pinz, Sophia et al. “Deacetylase inhibitors repress STAT5-mediated transcription by interfering with bromodomain and extra-terminal (BET) protein function.” Nucleic acids research vol. 43,7 (2015): 3524-45. doi:10.1093/nar/gkv188
• Pinz, Sophia et al. “The synthetic α-bromo-2',3,4,4'-tetramethoxychalcone (α-Br-TMC) inhibits the JAK/STAT signaling pathway.” PloS one vol. 9,3 e90275. 3 Mar. 2014, doi:10.1371/journal.pone.0090275
• Kumar, Amit et al. “Kaposi sarcoma herpes virus latency associated nuclear antigen protein release the G2/M cell cycle blocks by modulating ATM/ATR mediated checkpoint pathway.” PloS one vol. 9,6 e100228. 27 Jun. 2014, doi:10.1371/journal.pone.0100228
• Pinz, Sophia et al. “The natural chemopreventive agent sulforaphane inhibits STAT5 activity.” PloS one vol. 9,6 e99391. 9 Jun. 2014, doi:10.1371/journal.pone.0099391

Ilex Life Sciences LLC is an authorized distributor of PAN-Biotech products.